#+HashtagPLUS
In

Menu

U.S. IPO Weekly Recap: Biotech, Early-Stage Mining, And Bill Ackman Close Out The April IPO Market
📰
0

U.S. IPO Weekly Recap: Biotech, Early-Stage Mining, And Bill Ackman Close Out The April IPO Market

Seeking Alpha·Renaissance Capital IPO Research·about 1 month ago
#F4qghWvi
#source#chevron#alpha#ipos#priced#week
Reading 0:00
15s threshold

Summary

  • Four IPOs priced this past week, led by three sizable biotechs. They were joined by 11 blank check listings.
  • Two IPOs are currently scheduled for the week ahead, though some smaller names may join the calendar late.
  • Street research is expected for one company, and lock-up periods will be expiring for six companies.
Wooden toy cubes forming the abbreviation "IPO". Initial public offering, Stock exchange, shares

aprott/iStock via Getty Images

Four IPOs priced this past week, led by three sizable biotechs. They were joined by 11 blank check listings.

Coagulation disorder biotech Hemab Therapeutics (COAG) upsized and priced at the high end to raise $302

Read More